BAY1214784   Click here for help

GtoPdb Ligand ID: 12784

Synonyms: BAY 1214784 | BAY-1214784 | BAY-784 | compound 5a [PMID: 32960053] | ent-5a [1]
Compound class: Synthetic organic
Comment: BAY1214784 is an oral, small molecule GnRH receptor antagonist [1]. It was designed to lower plasma LH levels in postmenopausal women as a mechanism to manage the hormone-driven symptoms of uterine fibroids.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 1
Rotatable bonds 8
Topological polar surface area 129.74
Molecular weight 672.11
XLogP 2.61
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1CC1[C@H]2C3(CCS(=O)(=O)CC3)C4=CC(=CC=C4N2S(=O)(=O)C5=CC=C(C=C5)F)C(=O)NCC6=NC=C(C=C6Cl)C(F)(F)F
Isomeric SMILES ClC1=C(CNC(C2=CC=C3N(S(=O)(C4=CC=C(F)C=C4)=O)[C@@H](C5CC5)C6(CCS(CC6)(=O)=O)C3=C2)=O)N=CC(C(F)(F)F)=C1
InChI InChI=1S/C29H26ClF4N3O5S2/c30-23-14-19(29(32,33)34)15-35-24(23)16-36-27(38)18-3-8-25-22(13-18)28(9-11-43(39,40)12-10-28)26(17-1-2-17)37(25)44(41,42)21-6-4-20(31)5-7-21/h3-8,13-15,17,26H,1-2,9-12,16H2,(H,36,38)/t26-/m0/s1
InChI Key PZGSYNNVPNLHQG-SANMLTNESA-N
No information available.
Summary of Clinical Use Click here for help
A first in human study of BAY1214784 has been completed.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT02212080 First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784 Phase 1 Interventional Bayer